Zdrowie i gospodarka · 13/05/2026
Biomarker Incubator: Urinary Kidney Safety Biomarkers; Request for Information
The FDA's Center for Drug Evaluation and Research (CDER) is seeking information on a regulatory science initiative focused on validating biomarkers for drug-induced kidney injury. The initiative aims to compile data from multiple sources and enhance interactions between stakeholders and the FDA.